According to the research paper Introduction to Molecular Diagnostics, rapid point to point COVID-19 diagnostics are being developed in the molecular diagnostics field. Molecular diagnostics uses a collection of techniques to analyze and capture the genetic material or proteins associated with a specific health condition or disease.
Achieving scalable, reliable results and meeting demand
TAQ polymerase can be grown and harvested from bacterial cells (E. Coli). To liberate the enzyme from the cells, Microfluidizer® technology is an ideal solution (for lab-scale development) and can be used to directly and reliably scale up to large batches which will accommodate the massive diagnostic demand resulting from the Covid-19 pandemic.
Technology for Scalable Vaccine Production
Microfluidics supplies both lab-scale and full production scale, High Shear Homogenisers that are suitable for virus diagnostic component development and production. Read our Application Note to see how our technology is linearly scalable so that the results achieved in the lab are also possible at pilot and production-scale.